Author

Stephen C. Searles

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alex BarroniD· 1 shared Christella E. WidjajaiD· 1 shared Christopher J. StairikeriD· 1 shared Christopher P. DilloniD· 1 shared Edward Pyszczynski· 1 shared Eleanore Hendrickson· 1 shared Fang JiniD· 1 shared Graham D. ThomasiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex BarronORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 26, 2025

Therapeutic Blockade of Type 2 Cytokines and PD1 Unleashes Anti-Tumor Immunity Through Coordinated Reprogramming of Innate and Adaptive Immune Surveillance

Thomas Fabre, Eleanore Hendrickson, Katherine McGourty…·Alex Barron

This study shows that blocking type 2 cytokines and PD1 enhances anti-tumor immunity by reprogramming immune cells in both in vitro and in vivo models.

DOI 10.1101/2025.09.26.678820

mousebulk RNA-seq

𝕏 PostBluesky